UNILEXA exoskeleton for rehab and clinics by Mebster

UNILEXA is a modular exoskeleton platform solution with interchangeable parts that can be added and configured in different ways to suit a wider group of customers. It is a purely passive mechanical approach, without actuators, sensors or autonomous control systems. Instead, the system uses the body's own small shifts in weight and a unique combination of gravity-controlled and elastic mechanisms to assist walking while supporting the user's body weight. The core system uses a unilateral passive exoskeleton with locked knees and feet that are always close to the ground. This type of walking is stable in the anterior-posterior direction. In addition, a special medial joint design provides high lateral stability. MEBSTER's unique system of interconnected joints provides more stable and efficient walking.

UNILateral Exoskeleton for Assisted Walking (UNILEXA), developed for people with complete or partial loss of lower limb function, especially paraplegics, is the result of many years of research and development in the field of biomechanics and biorobotics.

The term unilateral refers to a one-sided attachment of the device to the lower limbs, with the medial support determining the position from the inside of the limbs. This setting ensures optimal ease of use and reduces the risk of edema, skin problems and other complications associated with the use of bilateral orthoses. In addition, the medial design allows easy donning and doffing of the orthosis directly from the wheelchair.

The PRIME version is intended for use in medical centers and hospitals. The device consists of interchangeable and adjustable parts that allow customization for each patient based on their anthropometry. By adjusting the height of the device and the mutual position of the orthotic joints to the appropriate anatomical landmarks, each patient can be optimally equipped to achieve better performance and reach their full potential. The adjustable and interchangeable orthotic sleeves provide an optimal fit to the user's body for greater comfort. Although UNILEXA Prime is not as custom-made as the made-to-measure Home version, its features make it reliable and comfortable, providing a positive user experience.

• Especially traumatic spinal cord injuries
• Traumatic brain injuries
• Tumors
• ICP patients with polio and post-polio syndrome (see spasticity at fixed rate after MAS).
• Myopathy
• Spina bifida (MMC)
• Multiple sclerosis
• Other unspecified cases Users with partial or complete paralysis or limited function of lower limbs only after approval by a physician

• Spasticity (more than 2 according to MAS)
• Pressure sores and pressure ulcers in places that clamp the device to the user's body
• Autonomic dysreflexia
• Instability of the spine
• Untreated deep vein thrombosis
• Undertreated limb or pelvic fractures
• Advanced osteoporosis with deformities of the lower limbs
• Complete quadriplegia
• Lack of ability to control upper limbs (ASIA grade 3 or less).
• Balance disorders
• Severe mental retardation
• Severe dizziness
• Heart problems
• Heterotopic ossification
• Orthostatic hypotension

STABLE WALKING WITH LOW ENERGY CONSUMPTION

Thanks to its sophisticated, patented design and unique joint connection system, UNILEXA ensures a more stable and efficient gait that consumes less energy compared to other mechanical orthoses and exoskeletons.

MODULARITY

The exoskeleton itself is a modular system with two newly developed ankle joints and a medial hip joint connected to form a functional unit. Individual joints can be easily replaced during inspection and serviced as needed.

CLINICAL ADVANTAGES OF THE USE OF UNILEXA

Verticalization, early mobilization and ambulation after an accident can prevent many secondary health problems, such as:

• Posture improvement
• Breathing improvement
• Reduction of neuropathic pain
• Reduction of the risk of obesity
• Prevention of digestive problems
• Prevention of urinary tract infections
• Reduction of anxiety and depression
• Reduction of the risk of heart disease
• Prevention of pressure ulcers and skin problems
• Reduction of bone loss, osteoporosis and fractures.
• Prevention of infections of the digestive tract and other organs.
• Reduce spasticity and muscle atrophy by maintaining partial function of the lower limbs.